Correlation Between Tff Pharmaceuticals and Akero Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tff Pharmaceuticals and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tff Pharmaceuticals and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tff Pharmaceuticals and Akero Therapeutics, you can compare the effects of market volatilities on Tff Pharmaceuticals and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tff Pharmaceuticals with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tff Pharmaceuticals and Akero Therapeutics.
Diversification Opportunities for Tff Pharmaceuticals and Akero Therapeutics
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Tff and Akero is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Tff Pharmaceuticals and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Tff Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tff Pharmaceuticals are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Tff Pharmaceuticals i.e., Tff Pharmaceuticals and Akero Therapeutics go up and down completely randomly.
Pair Corralation between Tff Pharmaceuticals and Akero Therapeutics
Given the investment horizon of 90 days Tff Pharmaceuticals is expected to under-perform the Akero Therapeutics. In addition to that, Tff Pharmaceuticals is 2.77 times more volatile than Akero Therapeutics. It trades about -0.09 of its total potential returns per unit of risk. Akero Therapeutics is currently generating about 0.07 per unit of volatility. If you would invest 2,313 in Akero Therapeutics on September 3, 2024 and sell it today you would earn a total of 897.00 from holding Akero Therapeutics or generate 38.78% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tff Pharmaceuticals vs. Akero Therapeutics
Performance |
| Timeline |
| Tff Pharmaceuticals |
| Akero Therapeutics |
Tff Pharmaceuticals and Akero Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tff Pharmaceuticals and Akero Therapeutics
The main advantage of trading using opposite Tff Pharmaceuticals and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tff Pharmaceuticals position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.| Tff Pharmaceuticals vs. DiaMedica Therapeutics | Tff Pharmaceuticals vs. Lyra Therapeutics | Tff Pharmaceuticals vs. Centessa Pharmaceuticals PLC |
| Akero Therapeutics vs. Terns Pharmaceuticals | Akero Therapeutics vs. Madrigal Pharmaceuticals | Akero Therapeutics vs. Inozyme Pharma | Akero Therapeutics vs. Viking Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |